NLRP3 and steatosis: However, we and others have demonstrated elsewhere that inhibition of AGEs production or blocking of AGE/RAGE signalling reverses both SREBP1c and NLRP3 upregulation, concomitantly improving steatosis and inflammation43,60–63.